Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Down – Here’s What Happened

by · The Cerbat Gem

Shares of Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $11.84, but opened at $11.06. Fresenius SE & Co. shares last traded at $11.0450, with a volume of 18,359 shares trading hands.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research note on Monday, April 20th. Citigroup reiterated a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy”.

View Our Latest Report on Fresenius SE & Co.

Fresenius SE & Co. Stock Down 2.8%

The firm has a 50 day simple moving average of $12.43 and a two-hundred day simple moving average of $13.67. The company has a quick ratio of 1.00, a current ratio of 1.32 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $24.90 billion, a P/E ratio of 14.73 and a beta of 0.68.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). The company had revenue of $6.75 billion for the quarter, compared to analyst estimates of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.29% and a net margin of 6.55%. On average, equities research analysts expect that Fresenius SE & Co. will post 1.05 earnings per share for the current year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.

See Also